RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$24.06
-1.55%
Mkt Cap $1.21B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (16 analysts)
$67.00
Range $52.00 – $80.00
Implied Upside
+178.5%
Consensus $67.00 vs current $24.06